InfuSystem Holdings, Inc (INFU) stock forecast and price target
Price $14.72 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($14.72)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $0.49 | — | $145M |
| Next fiscal year ends December 31, 2027 | $0.56 | +14.3% | $154M |
| Next quarter ends December 31, 2026 | $0.14 | — | $37M |
| Quarter after ends March 31, 2027 | $0.07 | — | $35M |
Consensus of the analysts covering InfuSystem, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 25.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts InfuSystem’s intrinsic value about 42% below today’s market value, and it scores 2.6 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the InfuSystem stock price target?
The average 12-month target from 3 analysts is $18.50, 25.7% above the current price of $14.72 Targets range from $17.50 to $20.00.
Is InfuSystem a buy according to analysts?
The consensus rating is “Strong buy” (3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is InfuSystem expected to earn?
Analysts expect EPS of $0.49 for the fiscal year ending December 31, 2026 and $0.56 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.